Top banner
Subscribe
MY AMERICAN SCIENTIST
LOG IN! REGISTER!
SEARCH
 
Logo

SCIENCE IN THE NEWS DAILY

Study Suggests Drug Can Cut Risk of Cancer's Return

from the Baltimore Sun

CHICAGO (Associated Press) - A drug to prevent bone loss during breast cancer treatment also substantially cut the risk that the cancer would return, results that left doctors excited about a possible new way to fight the disease.

It is the first large study to affirm wider anti-cancer hopes for Zometa and other bone-building drugs called bisphosphonates. Zometa, made by Novartis AG, is used now for cancers that have already spread to the bone.

The new study involved 1,800 premenopausal women taking hormone treatments for early-stage breast cancer. Zometa cut by one-third the chances that cancer would recur—in their bones or anywhere else.

Read more ...


comments powered by Disqus
 

EMAIL TO A FRIEND :


Bottom Banner